Order Article Reprints

Richter K, Ogiemwonyi-Schaefer R, Wilker S, Chaveiro AI, Agné A, Hecker M, Reichert M, Amati A-L, Schlüter K-D, Manzini I, et al. Amyloid Beta Peptide (Aβ_1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release. Journal of Clinical Medicine. 2020; 9(9):2887. https://doi.org/10.3390/jcm9092887

Richter, Katrin, Raymond Ogiemwonyi-Schaefer, Sigrid Wilker, Anna I. Chaveiro, Alisa Agné, Matthias Hecker, Martin Reichert, Anca-Laura Amati, Klaus-Dieter Schlüter, Ivan Manzini, and et al. 2020. "Amyloid Beta Peptide (Aβ_1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release" Journal of Clinical Medicine 9, no. 9: 2887. https://doi.org/10.3390/jcm9092887

Richter, K., Ogiemwonyi-Schaefer, R., Wilker, S., Chaveiro, A. I., Agné, A., Hecker, M., Reichert, M., Amati, A.-L., Schlüter, K.-D., Manzini, I., Schmalzing, G., McIntosh, J. M., Padberg, W., Grau, V., & Hecker, A. (2020). Amyloid Beta Peptide (Aβ_1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release. Journal of Clinical Medicine, 9(9), 2887. https://doi.org/10.3390/jcm9092887